Yüklüyor......
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation
Background: Ovarian cancer is the fifth most common cancer in the UK, and the fourth most common cause of cancer death. Of those people successfully treated with first-line chemotherapy, 55–75% will relapse within 2 years. At this time, it is uncertain which chemotherapy regimen is more clinically e...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
NIHR Journals Library
2015-01-01
|
| Seri Bilgileri: | Health Technology Assessment |
| Konular: | |
| Online Erişim: | https://doi.org/10.3310/hta19070 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|